Friday 27 April 2018

Valeant to buy 'Female Viagra' firm

Canada's Valeant Pharmaceuticals International said on Thursday it would buy Sprout Pharmaceuticals, maker of the first approved treatment for low sexual desire in women, for about $1 billion plus milestone payments. Sprout


Canada's Valeant boosts $53bn Allergan takeover bid

Valeant Pharmaceuticals International said it would boost its takeover bid for Botox-maker Allergan for the second time this week, contingent on the two sides negotiating. Laval, Quebec-based Valeant said it would pay $72 in cash


FDA backs GSK, Valeant epilepsy drug

The US Food and Drug Administration gave its limited approval on Monday for GlaxoSmithKline's and Valeant Pharmaceuticals International's  new epilepsy drug Potiga. The drug, known generically as ezogabine, will not be availab

 1 2 3 4 5 >  Last ›

calendarCalendar of Events